Short answer
Eton Pharmaceuticals, Inc. (ETON) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Press release presents Adjusted EBITDA as a non-GAAP performance metric alongside U.S. GAAP results.
Eton Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Press release presents Adjusted EBITDA as a non-GAAP performance metric alongside U.S. GAAP results
- Management uses Adjusted EBITDA for budgeting, internal projections, strategy evaluation and board communications
- Metric excludes items considered non-core, enabling comparisons across reporting periods and acquisitions
- Investors should review the accompanying U.S. GAAP reconciliation before relying on Adjusted EBITDA performanceેણ
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Eton Pharmaceuticals, Inc. 8-K filings
Get the next ETON 8-K as it lands
Follow ETON for push alerts, or ask the research agent what this filing means.